###begin article-title 0
Polymorphisms in the Estrogen Receptor 1 and Vitamin C and Matrix Metalloproteinase Gene Families Are Associated with Susceptibility to Lymphoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: CFS RAP MTS. Performed the experiments: AN RAP DRS LA. Analyzed the data: PRB EH AN AH SS. Wrote the paper: CFS. Performed pathology: PT. Performed bioinformatics: MSF LC. PI of U.S. study: EAH. PI of German study: NB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Non-Hodgkin lymphoma (NHL) is the fifth most common cancer in the U.S. and few causes have been identified. Genetic association studies may help identify environmental risk factors and enhance our understanding of disease mechanisms.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 677 678 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 880 884 880 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 979 983 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1348 1352 1348 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 1358 1362 1358 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 1441 1448 1441 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 1454 1461 1454 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 274 277 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 279 291 <span type="species:ncbi:9606">participants</span>
768 coding and haplotype tagging SNPs in 146 genes were examined using Illumina GoldenGate technology in a large population-based case-control study of NHL in the San Francisco Bay Area (1,292 cases 1,375 controls are included here). Statistical analyses were restricted to HIV- participants of white non-Hispanic origin. Genes involved in steroidogenesis, immune function, cell signaling, sunlight exposure, xenobiotic metabolism/oxidative stress, energy balance, and uptake and metabolism of cholesterol, folate and vitamin C were investigated. Sixteen SNPs in eight pathways and nine haplotypes were associated with NHL after correction for multiple testing at the adjusted q<0.10 level. Eight SNPs were tested in an independent case-control study of lymphoma in Germany (494 NHL cases and 494 matched controls). Novel associations with common variants in estrogen receptor 1 (ESR1) and in the vitamin C receptor and matrix metalloproteinase gene families were observed. Four ESR1 SNPs were associated with follicular lymphoma (FL) in the U.S. study, with rs3020314 remaining associated with reduced risk of FL after multiple testing adjustments [odds ratio (OR) = 0.42, 95% confidence interval (CI) = 0.23-0.77) and replication in the German study (OR = 0.24, 95% CI = 0.06-0.94). Several SNPs and haplotypes in the matrix metalloproteinase-3 (MMP3) and MMP9 genes and in the vitamin C receptor genes, solute carrier family 23 member 1 (SLC23A1) and SLC23A2, showed associations with NHL risk.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our findings suggest a role for estrogen, vitamin C and matrix metalloproteinases in the pathogenesis of NHL that will require further validation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 305 308 305 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Alexander1">[1]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola1">[2]</xref>
###xml 776 779 776 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Rui1">[3]</xref>
###xml 1824 1827 1812 1815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola1">[2]</xref>
###xml 1829 1832 1817 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Forrest1">[4]</xref>
###xml 1833 1837 1821 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Willett1">[12]</xref>
###xml 2058 2065 2046 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t001">Table 1</xref>
Non-Hodgkin lymphoma (NHL) is the most common hematopoietic cancer diagnosed in the U.S. Rates have increased steadily over the last 30 years (). Known risk factors include family history, exposure to infectious agents and immunodeficiency associated with congenital conditions and post-transplant therapy[1], though the causes for most cases are unknown. Genetic and environmental factors that influence the growth, survival and capacity of B-cells with pre-neoplastic changes to undergo transformation[2] or that impact the quality of tumor-specific immune responses may play integral roles in lymphomagenesis. Approximately 80% of lymphomas are of B-cell origin that arise during germinal center (GC) and post-GC reactions as part of otherwise normal B-cell differentiation[3]. Diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) are major lymphoma histologies that collectively comprise approximately75% of all NHL in industrialized countries. Whereas DLBCL is a clinically aggressive disease for which incidence increases with age, FL and SLL/CLL present a more indolent clinical course. Molecular and phenotypic differences between NHL histologies suggest they may have distinct etiologies, though overlapping mechanisms are likely. The study of candidate single nucleotide polymorphisms (SNPs) may help to identify environmental risk factors, further elucidate disease mechanisms and discover novel targets for lymphoma treatment regimens. Thus, we undertook a genetic study of 768 coding and haplotype tagging SNPs in 146 genes in a population-based case-control study of NHL in the San Francisco Bay Area (1,292 cases, 1,375 controls). The genes investigated were primarily selected based on findings from our earlier genetic studies[2], [4]-[12] in pathways involved in steroidogenesis, immune function, cell signaling, sunlight exposure, xenobiotic metabolism/oxidative stress, energy balance, as well as uptake and metabolism of cholesterol, folate and vitamin C (Table 1). The most compelling associations were tested in an independent population-based case-control study of lymphoma based in Germany.
###end p 9
###begin title 10
Pathways/gene functional groups of analyzed candidate genes in the San Francisco Bay Area NHL study.
###end title 10
###begin title 11
Results
###end title 11
###begin title 12
Assessment of sample completion rates and SNP call rates
###end title 12
###begin p 13
###xml 667 668 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1130 1131 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 1231 1239 1227 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Tables 2</xref>
###xml 1244 1245 1240 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">3</xref>
###xml 1267 1268 1263 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1369 1370 1365 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1383 1390 1379 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 48 60 <span type="species:ncbi:9606">participants</span>
###xml 164 176 <span type="species:ncbi:9606">participants</span>
Of the 768 SNPs genotyped in DNA of 2,667 study participants (1,292 cases and 1,375 controls) from a large population-based case-control study with more than 4,100 participants, eight samples were excluded from further analyses due to missing SNP data (>10%) yielding a sample completion rate of 99.7%. After restriction to white non-Hispanics, 959 cases and 1,049 controls were included in the final analysis. A total of 62 SNPs with call rates <90% were dropped from the analysis yielding a SNP call rate of 91.9%. Additional dropped SNPs included those with minor allele frequencies <5% (n = 29), X chromosome SNPs (n = 7) and SNPs with Hardy-Weinberg equilibrium p-values<0.01 (n = 33) leaving a total of 637 SNPs for subsequent analyses. Two pairs of replicate DNAs on each plate revealed genotype concordance rates of >99% within and between plates. Genotype results concurred (>98.5%) with data from the quality control Taqman genotyping of 10 SNPs on the same study population. Single-marker allelic tests for all SNPs were performed using chi2 statistics. SNPs and haplotypes with the strongest statistical associations (q-values</=0.10) adjusted for multiple comparisons using the false discovery rate (FDR) are shown in Tables 2 and 3, respectively, while p-values for all SNPs are available online (website). None of the associated SNPs violated HWE at the p<0.05 level (Table 2).
###end p 13
###begin title 14
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt102">*</xref>
SNPs associated with NHL with corrected p-values (q)<0.10* for the San Francisco Bay Area NHL case-control study.
###end title 14
###begin p 15
MAF: minor allele frequency; NHL: non-Hodgkin lymphoma; FL: follicular lymphoma; DLBCL: diffuse large B-cell lymphoma; SLL: small lymphocytic lymphoma; CLL: chronic lymphocytic leukemia.
###end p 15
###begin p 16
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
q<0.05 are in bold.
###end p 16
###begin title 17
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
Associated haplotypes with corrected p-values (q)<0.10 for the San Francisco Bay Area NHL case-control study.
###end title 17
###begin p 18
NHL: non-Hodgkin lymphoma; FL: follicular lymphoma; DLBCL: diffuse large B-cell lymphoma; SLL: small lymphocytic lymphoma; CLL: chronic lymphocytic leukemia.
###end p 18
###begin title 19
Gene- and SNP-based analyses
###end title 19
###begin title 20
SNPs in vitamin C receptor genes influence risk of NHL, FL and SLL/CLL
###end title 20
###begin p 21
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 236 238 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s005">Table S1</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
SNP-specific analyses revealed that both SNPs genotyped in the vitamin C receptor gene, solute carrier family 23 member 1 (SLC23A1), rs6596473 (IVS13+2515G>C) and rs11950646 (IVS9-110A>G), influenced risk of FL (p = 2.5x10-2, q = 8.4x10-2, Table 2). Those homozygous variant for either SNP had an 80% elevated risk of FL (Table S1). These SNPs captured 75% of the haplotype structure in SLC23A1 (R2 = 0.99) though no haplotype associations were found.
###end p 21
###begin p 22
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 155 157 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s005">Table S1</xref>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s005">Table S1</xref>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 703 710 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 740 747 740 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 760 769 760 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s001">Figure S1</xref>
###xml 832 839 820 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 912 913 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1026 1033 1014 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">Table 3</xref>
###xml 1308 1309 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1330 1337 1318 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
An intronic SLC23A2 SNP rs1776948 (IVS2-17750G>A) influenced NHL (p = 4.7x10-3, q = 4.3x10-2), FL (p = 2.0x10-2, q = 8.4x10-2) and SLL/CLL risk (p = 1.1x10-3, q = 3.0x10-2). In logistic regression analyses, the rs1776948 homozygous variant 17750AA genotype was positively associated with disease risk (Table S1). Notable associations were observed for two additional intronic SLC23A2 SNPs, rs6133175 (IVS4+1767A>G) and rs1715364 (IVS3+14205T>C) (q<0.05), where the homozygous variant genotypes yielded two-fold increased risks for SLL/CLL (Table S1). TFSEARCH () predicted that the SLC23A2 rs1715364 wild type T allele creates binding sites for the GATA-1 and GATA-2 enhancer proteins that may increase SLC23A2 expression. LD structure for SLC23A2 is shown in Figure S1. Given the size of this gene (approximately158 Kb), the seven SLC23A2 tag SNPs genotyped only captured 35% of its haplotype structure at the R2 = 0.94 level. Though gene coverage was low, haplotype associations were found with NHL, DLBCL and SLL/CLL risk (Table 3). A two-SNP AA haplotype (rs1776948 and rs6139587) was positively associated with NHL and SLL/CLL and an AAC haplotype derived from minor alleles for rs1715385 and rs1715364 and the wildtype allele for rs6133175 was associated with increased risk of NHL and DLBCL. However, p-values derived from SLC23A2 haplotype associations predicted no greater risks beyond those observed for the individual SNPs.
###end p 22
###begin title 23
Matrix metalloproteinase (MMP)3 and MMP9 SNPs influence FL and SLL/CLL risk
###end title 23
###begin p 24
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 125 127 125 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 256 264 256 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s006">Table S2</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Fairbrother1">[13]</xref>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A significant association was found between FL and a non-synonymous MMP3 45K>E SNP, (rs679620, A>G) (p = 3.7x10-4; q = 1.2x10-2; Table 2). Logistic regression analyses revealed that the MMP3 45EE allelotype was associated with a 70% increased risk for FL (Table S2). RESCUE ESE[13] predicted that the MMP3 45E variant introduces two exonic splicing enhancer motifs that could augment exon 2 splicing and increase MMP3 expression. This SNP, together with rs615098, located in the MMP3 promoter region, captured 44% of all common HapMap SNPs in the region at a mean R2 of 0.99.
###end p 24
###begin p 25
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Tables 2</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s006">S2</xref>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 485 487 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 499 501 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Tables 2</xref>
###xml 513 521 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s006">Table S2</xref>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 793 802 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s002">Figure S2</xref>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 904 905 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Two non-synonymous SNPs in MMP9 (279Q>R, rs17576; 668R>Q, rs2274756) influenced SLL/CLL status (p = 7.0x10-3, q = 9.5x10-2; p = 1.0x10-2, q = 9.5x10-2, respectively; Tables 2, S2). For the 668Q allele, ESEfinder identified an extra SF2/ASF motif that could enhance exon 2 splicing and increase MMP9 expression. Interestingly, the 668R>Q SNP was in complete LD with a MMP9 promoter SNP, rs3918241 (D' = 1.0), where the variant A allele was positively associated with SLL/CLL (p = 1.0x10-2; q = 9.5x10-2; Tables 2, Table S2). TFSEARCH predicts that the rs3918241 A allele creates extra GATA-1, Oct-1, GATA-2 and GATA-X binding motifs, suggesting increased promoter activity for the variant A allele. MMP9 variation was organized into a single LD block spanning the gene and its promoter region (Figure S2). Thus, the five MMP9 SNPs genotyped captured 78% of all common variation for this region at a mean R2 of 0.98.
###end p 25
###begin title 26
Sex hormone SNPs influence risk of lymphoma
###end title 26
###begin p 27
###xml 29 36 29 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19A1</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 464 472 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s007">Table S3</xref>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 661 669 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s006">Table S2</xref>
###xml 772 780 772 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s007">Table S3</xref>
###xml 783 790 783 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 864 871 864 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 905 906 905 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 915 917 915 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 919 920 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 929 931 929 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 933 940 933 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">Table 3</xref>
###xml 1271 1278 1271 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 1280 1289 1280 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s003">Figure S3</xref>
###xml 1374 1381 1374 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 1418 1419 1418 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The regression analyses (see methods) revealed an association between the cytochrome P450 (CYP)19A1 gene and risk for FL (p = 6.3x10-3). Eight CYP19A1 SNPs influenced risk for FL and SLL/CLL, though considering a q<0.10, only rs1870049 (IVS1+5469T>C) remained associated with disease status (p = 6.0x10-4; q = 4.9x10-2, Table 2). In logistic regression analyses, the rs1870049 homozygous variant CC genotype was associated with a three-fold increased risk for FL (Table S3). Four additional CYP19A1 SNPs, rs10046 (3'UTR, 1678T>C), rs2289105 (IVS7-79T>C), rs2899472 (IVS4-1334C>A), rs9944225 (IVS3+7029C>A) and rs4774584 (IVS1-26860G>A) influenced SLL/CLL risk (Table S2) and rs2008691 (IVS1-13201A>G) was positively associated with the group of "other" lymphoma subtypes (Table S3). CYP19A1 SNP associations did not differ by sex (data not shown). We also found a CYP19A1 five-SNP high-risk FL haplotype (p = 6.5x10-4, q = 2.9x10-2, Table 3) that included the rs1870049 variant C allele. A haplotype with the rs1870049 T allele did not influence FL risk, suggesting that the C allele was driving the haplotype association. Analysis of LD structure throughout the region revealed that the haplotype lies within an 18 kb region of relatively high LD spanning the 5' UTR of CYP19A1 (Figure S3). The 14 genotyped SNPs, uniformly distributed throughout the gene, captured 66% of CYP19A1 common genetic variation at a mean R2 of 0.96.
###end p 27
###begin p 28
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 142 144 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 146 153 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 299 307 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s008">Table S4</xref>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 646 654 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s008">Table S4</xref>
###xml 844 853 844 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s004">Figure S4</xref>
###xml 884 888 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1095 1099 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
An intronic SNP, rs3020314 (IVS4+5029T>C), in the estrogen receptor alpha (ESR1) gene was associated with risk of FL (p = 1.6x10-3, q = 7.0x10-2, Table 2). Logistic regression analyses revealed that the rs3020314 homozygous variant IVS4+5029CC genotype was associated with a 58% reduced risk of FL (Table S4). This SNP was in almost complete LD (D'>0.9,R2>0.90) with three other SNPs that form part of a 14 kb haplotype block of 9 common SNPs located between exons 4 and 5. Homozygous variant genotypes for three additional ESR1 SNPs, rs488133 (promoter-3604C>T), rs532010 (IVS1+1419T>C) and rs827423 (IVS1-7534T>C) also were associated with FL (Table S4). These three SNPs formed part of a major haplotype block that extended 43 kb from the 5' upstream region to exon 2, which includes another 32 HapMap genotyped SNPs. LD structure analysis (Figure S4) revealed that some of the 11 ESR1 SNPs genotyped in this study are located at the borderlines of blocks close to recombination hotspots. These SNPs, at a density of one every approximately28 Kb, captured only 25% of the common variation in ESR1.
###end p 28
###begin title 29
Other genetic associations with NHL
###end title 29
###begin p 30
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR1H2</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 183 185 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR1H2</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20T&gt;C</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDFT1</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 461 463 461 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 475 477 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 514 516 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDFT1</italic>
###xml 727 728 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 737 739 737 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 741 742 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 751 753 751 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 755 762 755 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">Table 3</xref>
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDFT1</italic>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDFT1</italic>
###xml 979 984 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDFT1</italic>
###xml 987 988 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
In the cholesterol genes, considering q-values<0.10, we found an association between NHL and the nuclear receptor subfamily 1, group H, member 2 (NR1H2) gene (p = 1.8x10-3, q = 3.5x10-2) in the regression analysis. NR1H2 is involved in cholesterol homeostasis and bile acid metabolism. For FL, we found gene and SNP (20T>C) associations with farnesyl-diphosphate farnesyltransferase 1(FDFT1), which plays a key role in cholesterol biosynthesis (gene, p = 4.1x10-3; q = 7.8x10-2; rs1047643, p = 8.4x10-4, q = 5.2x10-2, Table 2). According to ESEfinder, the rs1047643 C allele introduces an extra SRp55 motif that may influence pre-mRNA processing or splicing efficiency. This SNP was included in a FL high-risk FDFT1 haplotype (p = 1.6x10-3, q = 6.4x10-2, Table 3), though the p-value was no more significant for the haplotype than for the rs1047643 SNP association. No other FDFT1 SNP associations were observed. The four FDFT1 SNPs genotyped captured 52% of common variation in FDFT1 (R2 = 0.92).
###end p 30
###begin p 31
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL6</italic>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB2</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 290 292 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">Table 3</xref>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB2</italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB2</italic>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
In cell signaling genes, we found an association with NHL and the BCL6 gene (p = 3.4x10-3, q = 7.8x10-2), though no single SNP significantly influenced risk. We also found that an intronic SNP rs760462 (IVS3+2100G>A) in integrin beta 2 (ITGB2) influenced FL status (p = 9.7x10-4, q = 7.2x10-2, Table 2), where the 2100AA genotype increased FL risk three-fold (Table 3). No other associations were found with ITGB2, however the six SNPs genotyped captured only 21% of the variation in the ITGB2 gene (R2 = 0.99).
###end p 31
###begin p 32
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPHX2</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 156 158 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPHX2</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPHX2</italic>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 506 508 506 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">Table 3</xref>
###xml 700 703 700 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIK</italic>
###xml 756 763 756 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 836 839 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIK</italic>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
For SLL/CLL, the variant allele for rs4149244 (IVS9+1573C>T) in the epoxide hydrolase 2 (EPHX2) gene was positively associated with disease risk (p = 1.2x10-3, q = 4.5x10-2, Table 2). TFSEARCH predicts that the T allele introduces a CdxA binding site, suggesting that this allele may act to enhance EPHX2 gene expression. Gene coverage for the four EPHX2 SNPs genotyped was 58% (R2 = 0.96). The rs414924 T allele also comprised a two-SNP haplotype that was associated with FL risk (p = 1.0x10-3, q = 2.0x10-2, Table 3), though again the haplotype was no more likely to contribute to risk than the rs4149244 SNP. Finally, a five-SNP haplotype in the apoptosis/signaling gene, BCL2-interacting killer (BIK) was associated with an increased risk for SLL/CLL (Table 2), though no SNP associations were detected. Gene coverage for the seven BIK SNPs genotyped was 75% (R2 = 0.95).
###end p 32
###begin title 33
Validation Study
###end title 33
###begin p 34
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Table 2</xref>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 524 531 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 560 567 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 671 678 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t004">Table 4</xref>
We next tested for association of significant findings in an independent case-control study of lymphoma in Germany that comprised 494 NHL cases and 494 age and sex-matched controls. An additional 111 Hodgkin lymphoma cases and 111 matched controls also were analyzed. The criterion used for selection of SNPs in Table 2 was that there was >1 associated signal in a particular pathway and in more than one gene. When SNPs were closely linked (R2>0.8), only one SNP was chosen for validation. Eight SNPs were genotyped in the SLC23A1 (rs6596473, rs11950646) and SLC23A2 (rs1715364), MMP3 (rs679620), MMP9 (rs3918241), CYP19A1 (rs1870049, 2899472) and ESR1 (3020314) genes (Table 4).
###end p 34
###begin title 35
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 108 124 108 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1 and ESR1</italic>
Odds ratios (OR) and 95% confidence intervals (CI) for associated SNPs in the SLC23A1, SLC23A2, MMP3, MMP9, CYP19A1 and ESR1 genes in the San Francisco Bay Area NHL and German studies.
###end title 35
###begin p 36
ORs generated by conditional logistic regression.
###end p 36
###begin p 37
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 396 398 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 486 488 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 522 523 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 709 711 709 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 751 752 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 761 763 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
The SLC23A1 rs6596473 and rs11950646 SNPs associated with increased FL risk in the U.S. study (OR = 1.8, 95% CI = 1.2-2.9, p = 8.8x10-3 and OR = 1.8, 95% CI = 1.2-2.8, p = 8.3x10-3, respectively), did not influence risk of FL in the German study. However, in the German study, risk estimates were elevated for CLL (OR = 3.4, 95% CI = 0.91-13, p = 7.0x10-2; OR = 2.6, 95% CI = 0.85-7.9, p = 9.0x10-2, respectively) and ORs were reduced for DLBCL (OR = 0.39, 95% CI = 0.13-1.1, p = 8.0x10-2 and OR = 0.44, 95% CI = .17-1.1, p = 9.0x10-2, respectively). Consistent with the U.S. study, the SLC23A2 rs1715364 CC genotype was associated with an elevated OR for SLL/CLL (U.S.: OR = 1.9, 95% CI = 1.2-3.1, p = 5.5x10-3; Germany: OR = 1.8, 95% CI = 0.77-4.1, p = 1.8x10-1), though the confidence interval included one.
###end p 37
###begin p 38
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 155 157 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 325 326 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 335 337 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 522 523 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 584 586 584 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
For MMP3 rs679620 where the US study found an increased risk for FL associated with the homozygous variant genotype (OR = 1.7, 95% CI = 1.1-2.6, p = 1.9x10-2), the German study found no associations with NHL. However, the homozygous variant genotype was associated with an increased risk for HL (OR = 2.3, 95% CI = 0.99-5.4, p = 5.4x10-2). Consistent with findings in the U.S. study, homozygosity for the MMP9 rs3918241 variant resulted in an elevated OR for NHL approaching significance (US: OR = 1.7, 95% CI = 0.95-3.0, p = 7.4x10-2; Germany: OR = 2.5, 95% CI = 0.80-8.1; p = 1.0x10-1), however, there was no increased risk of CLL with the variant allele as found in the U.S. study.
###end p 38
###begin p 39
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 468 470 468 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 534 536 534 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 726 728 726 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
In the German study, CYP19A1 rs1870049 failed Pyrosequencing genotyping and no differences in rs2899472 allele frequencies were observed between cases and controls. The most robust findings were for ESR1 rs3020314 where, as in the US study, heterozygous and homozygous variant genotypes were inversely related with FL risk in the German study (U.S.: heterozygous OR = 0.64, 95% CI = 0.46-0.88, p = 6.2x10-3; homozygous variant OR = 0.42, 95% CI = 0.23-0.77, p = 5.1x10-3; Germany: heterozygous OR = 0.47, 95% CI = 0.22-1.0, p = 5.7x10-2; homozygous variant OR = 0.24, 95% CI = 0.06-.094, p = 4.0x10-2). The ESR1 rs3020314 variant allele also was associated with HL in the German study (OR = 0.61, 95% CI = 0.35-1.1, p = 7.7x10-2).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola1">[2]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Forrest1">[4]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Willett1">[12]</xref>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 1289 1290 1289 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 1315 1324 1315 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1717 1721 1717 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1820 1827 1820 1827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 1829 1836 1829 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 1842 1846 1842 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
Here, we report that SNPs in the vitamin C receptor and matrix metalloproteinase gene families and in genes involved in estrogen responsiveness may be risk alleles for NHL. Our main strategy was to use a hypothesis-driven approach to further examine genetic findings based on our earlier studies by genotyping SNPs in related pathways or in genes that share common biological functions to those previously associated with NHL [2], [4]-[12]. We selected potential functionally relevant SNPs including non-synonymous coding SNPs, and 1-15 haplotype tagging SNPs were genotyped based on known patterns of LD using data available from the HapMap CEU population. These tag SNPs captured an average 39% of all common SNPs (R2>0.8) in the studied genes and their flanking regions. We note that the low coverage in some genes may have precluded us from detecting additional NHL risk alleles. Analyses were restricted to white non-Hispanics with ancestry data to reduce population stratification. In 959 cases and 1,049 controls, we identified 14 unique SNPs in eight pathways and seven haplotypes associated with NHL after correction for multiple testing at the adjusted q<0.10 (estimated FDR) level, and seven SNPs and eight haplotypes remained significantly associated with lymphoma risk at the q<0.05 level. We utilized in silico algorithms to predict likely functional effects for associated SNPs. Next, in an independent case-control study of lymphoma, we performed a small replication analysis of associated SNPs that were chosen based on the criteria that multiple SNP-NHL associations were observed in the same gene or gene family. In doing so, we found a strong inverse association between FL and an intronic SNP in ESR1 in both study populations. Other associations were observed between risk of lymphoma subtypes and SLC23A1, SLC23A2, and MMP9 SNPs. Although several of these associations occurred within different NHL subtypes across the two study populations, the overall consistency of associations with specific genes provides some support that these genes might be associated with NHL risk. Replication in additional populations and investigation of molecular similarities and differences of NHL subtypes such as through tumor microarray studies will be needed to clarify these findings.
###end p 41
###begin title 42
Vitamin C and risk of NHL
###end title 42
###begin p 43
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Chang1">[14]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Talamini1">[15]</xref>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 727 734 727 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 870 877 870 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
The associations we identified between NHL and SNPs in the vitamin C receptor genes may provide indirect evidence to support epidemiological data showing inverse associations between NHL risk and intakes of fruits and vegetables, which are primary sources of dietary vitamin C [14], [15]. Here, we observed that homozygous variant genotypes for two closely linked intronic SLC23A1 SNPs, rs6596473 and rs11950646, were positively associated with FL in the U.S. study. However, in the German study, these genotypes were inversely and positively associated with DLBCL and SLL/CLL risk, respectively, suggesting that further study will be needed to determine the relevance, if any, of these findings. In the U.S. analysis of seven SLC23A2 SNPs, we found that variant alleles for rs6133175 and rs1715364 increased SLL/CLL risk and rs1776948 for FL and SLL/CLL. In genotyping SLC23A2 rs1715364 in the German study, the variant CC genotype was associated with an elevated OR for CLL, consistent with findings from the U.S. study. The haplotype analyses supported the genotype results but added nothing further to the individual SNP associations.
###end p 43
###begin p 44
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Savini1">[16]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Boyer1">[17]</xref>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slc23a1</italic>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slc23a2</italic>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Boyer1">[17]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Sotiriou1">[18]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Kuo1">[19]</xref>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 544 551 544 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 679 688 679 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 713 720 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 752 759 752 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 918 925 918 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 275 281 <span type="species:ncbi:9606">humans</span>
SLC23A1 and 2 encode two vitamin C transport proteins, SVCT1 and 2, respectively[16] that exhibit non-redundant functions[17]. The lethality of slc23a1 and slc23a2 mouse knockouts highlights the relevance of these proteins in maintaining vitamin C homeostasis [17], [18]. In humans, SVCT1 is expressed in kidney, intestinal, hepatic and placental tissues and is critical for vitamin C absorption and reabsorption, whereas SVCT2 is expressed in most tissues and is essential for vitamin C bioaccumulation[19]. Thus, the influence of SLC23A1 and SLC23A2 genetic variation on NHL risk suggests that both vitamin C uptake and storage may be involved in the pathogenesis of lymphoma. In silico models suggest that the SLC23A2 rs1715364 T allele may augment SLC23A2 expression and increase vitamin C bioavailability, which will need to be tested in functional studies. By extension, if the variant C allele results in lower SLC23A2 expression, then the increased NHL risk associated with the variant C allele might suggest that reduced vitamin C bioavailability increases lymphoma risk.
###end p 44
###begin p 45
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 305 314 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s001">Figure S1</xref>
###xml 330 337 330 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A1</italic>
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC23A2</italic>
As with the majority of SNPs investigated in this study, SLC23A1 and SLC23A2 SNPs were chosen as tag SNPs to gain gene coverage to capture potential causal variants. Though SLC23A1 and SLC23A2 have extensive sequence homology, SLC23A2 is a 10-fold larger gene with a much more complex locus architecture (Figure S1). Whereas, two SLC23A1 tag SNPs captured 75% of its haplotype structure, seven SLC23A2 tag SNPs captured only 35% of its haplotype structure at an R2>0.94, warranting the need for additional fine mapping of the SLC23A2 gene.
###end p 45
###begin p 46
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Lightfoot1">[5]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Linster1">[20]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Karyotou1">[21]</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Catani1">[22]</xref>
###xml 612 620 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Harakeh1">[23]</xref>
In pooled analyses of two NHL case-control studies, we previously reported that SNPs that impair anti-oxidant capacity may influence lymphomagenesis[5]. Vitamin C is an essential enzyme cofactor in reactions catalyzed by several metal-dependent oxygenases[20]. It also functions as a scavenger of reactive oxygen species[21] and, thus, may play an important role in preventing oxidative stress induced DNA damage by quenching free radical formation. Other possible modes of action may involve vitamin C's anti-tumorigenic role in supporting proper collagen formation and matrix stabilization[22]. Further, in an in vitro study of T-cell leukemia, vitamin C abrogated cell proliferation and induced apoptosis through p53, p21, Bcl-2 and Bax modulation[23]. Additional studies will be needed to clarify the role of vitamin C in the pathogenesis of NHL.
###end p 46
###begin title 47
MMP SNPs influence NHL, FL and SLL/CLL risk
###end title 47
###begin p 48
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Curran1">[24]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Stamenkovic1">[25]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Sato1">[26]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Kuittinen1">[27]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Ribatti1">[28]</xref>
###xml 773 776 773 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP</italic>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 1029 1033 1029 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 1163 1167 1163 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 1340 1344 1340 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 1459 1463 1459 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 1674 1678 1674 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
Extracellular matrix degradation is involved in many normal physiological processes including development, growth and tissue repair. However, high MMP-3 and -9 proteolytic enzyme levels also may support tumor cell proliferation, angiogenesis, invasion and metastasis[24], [25] by degrading type IV collagen, penetrating the basement membrane and invading surrounding tissues[26]. High MMP expression is found in lymphoid cells and malignantly transformed cells[27]. Recent studies highlight the relevance of MMPs and angiogenesis in lympho-hematological malignancies such as B-cell lymphoma, multiple myeloma, CLL and acute lymphocytic and myeloid leukemias[28]. While the MMP family has been related to cancer invasion and metastases, our study suggests that variation in MMP genes also plays a role in lymphomagenesis. Here we found that homozygosity for a non-synonymous MMP3 45K>E SNP, rs679620, was associated with increased risk of FL in the U.S. study, and for HL in the German study. It is biologically feasible that the MMP3 45EE allelotype may influence lymphomagenesis since it is predicted by RESCUE ESE to enhance exon 2 splicing, which may increase MMP3 expression. In the U.S. study, increased FL and SLL/CLL risk also was found in those possessing variant alleles for an MMP9 promoter SNP, rs3918241, and two non-synonymous MMP9 SNPs, rs17576 (279Q>R) and rs2274756 (668R>Q). According to ESEfinder, the rs3918241 variant A allele may enhance MMP9 promoter activity and the rs2274756 variant 668Q allelotype creates an extra binding motif that may enhance exon 2 splicing. Thus, the rs3918241 and rs2274756 risk alleles for SLL/CLL are predicted to increase MMP9 expression. We tested the association of rs3918241 in the German study and found an elevated though non-significant increase in NHL risk, consistent with the U.S. study, though there was no evidence of an association with FL and CLL as in the U.S. study. The 4% frequency of the homozygous variant genotype may have precluded us from observing these associations, which will require the study of this SNP in larger populations. Since rs3918241 and rs2274756 are in complete LD, additional studies also will be needed to discern which, if any, of these functionally relevant SNPs may be causally related to NHL.
###end p 48
###begin p 49
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEP</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEPR</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHRL</italic>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola4">[9]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola6">[11]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Willett1">[12]</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEPR</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEPR</italic>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHRL</italic>
###xml 607 608 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP</italic>
In earlier studies, we found associations with NHL and SNPs in energy regulation genes such as leptin (LEP), leptin receptor (LEPR) and ghrelin (GHRL)[9], [11], [12]. We hypothesized that leptin may promote lymphomagenesis through mitogenic and anti-apoptotic effects on B-cell populations through LEPR-mediated upregulation of BCL-2, MMPs, and tissue inhibitors of metalloproteinases. The present study lends further credence to the role of MMPs in lymphomagenesis. Interestingly, our study found multiple genetic associations with LEPR, GHRL and SNPs in other energy regulatory genes, though the adjusted q-values were >0.10. In light of these findings, we plan to further study the relationship between energy regulation and MMP SNPs in lymphomagenesis.
###end p 49
###begin title 50
ESR1 and CYP19A1 gene variants in association with lymphoma risk
###end title 50
###begin p 51
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP17A1</italic>
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola2">[7]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola5">[10]</xref>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP17A1</italic>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP17A1</italic>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 656 665 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s004">Figure S4</xref>
###xml 768 775 768 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 780 784 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 792 799 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Brodie1">[29]</xref>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1156 1163 1148 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 1172 1176 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Yang1">[30]</xref>
###xml 1198 1205 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
###xml 1289 1290 1281 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 1595 1602 1587 1594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19A1</italic>
Previously, we reported a CYP17A1-34T>C high-risk genotype for DLBCL in two independent case-control studies of NHL[7], [10]. CYP17A1 produces key enzymes that catalyze the synthesis of estrone and dehydroepiandrosterone, the precursors for estrogen and testosterone. These findings prompted us to explore SNPs in additional genes involved in steroidogenesis and in estrogen and testosterone uptake and metabolism. Unfortunately, in the present study, we were unable to obtain genotype calls for CYP17A1-34T>C due to poor genotype clustering. Additionally, we had insufficient SNP coverage across ESR1 since some tags were located in the lower LD regions (Figure S4). Nonetheless, in the U.S. study, our results revealed associations with NHL and multiple SNPs in the CYP19A1 and ESR1 genes. CYP19A1 encodes for aromatase, a key enzyme in estrogen production[29] that converts androstenedione and testosterone to estradiol and estrone, respectively. ESR1 encodes estrogen receptor 1 (ERalpha) that plays an important role in mediating estrogen action in target tissues. Moreover, ERalpha signaling regulates estrogen production by direct modulation of the CYP19A1 promoter[30]. Here we found seven CYP19A1 SNPs associated with forms of NHL and one, rs1870046, remained associated with FL (q<0.10). In the replication study, rs1870046 was not successfully genotyped and no associations were found between SLL/CLL and rs2899472. Given the extent of associated alleles in the U.S. study and that only one SNP was investigated in the German study, further investigation of associated alleles in the CYP19A1 gene is warranted.
###end p 51
###begin p 52
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Greendale1">[31]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Stavrou1">[32]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Watanabe1">[33]</xref>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Haruki1">[34]</xref>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Esr1</italic>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Bolstad1">[35]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Thurmond1">[36]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Gallagher1">[37]</xref>
###xml 907 910 907 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola2">[7]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Lee1">[38]</xref>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Nelson1">[39]</xref>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 515 518 <span type="species:ncbi:9606">men</span>
###xml 540 543 <span type="species:ncbi:9606">men</span>
###xml 548 553 <span type="species:ncbi:9606">women</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
The most significant finding in this study was the inverse association between FL and the C allele in ESR1 rs3020314 that was corroborated with FL and HL in the German study. Since estrogen exerts a biphasic dose-dependent effect on the immune system, this association may be biologically plausible. Notable but somewhat complex hormonal-driven associations have been reported between other ESR1 gene variants and breast cancer, spontaneous abortion, osteoporosis[31], age of menarche[32], genital abnormalities in men[33] and fertility in men and women. ESR1 is also expressed by thymocytes and B- and T-cells[34] and Esr1 knockout mice exhibit compromised thymic[35] and B-cell development[36], insulin resistance, impaired glucose tolerance and obesity[37]. Several epidemiological studies have reported that oral contraceptive use and hormone replacement therapy are associated with lower lymphoma risk [7], [38], [39]. Thus, large pooled gene-environment studies of ESR1 gene variants and measures of hormone levels or history of hormone use may be useful to further explore the role of hormones in the pathogenesis of lymphoma.
###end p 52
###begin title 53
Lack of additional genetic associations
###end title 53
###begin p 54
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIK</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPHX2</italic>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Skibola1">[2]</xref>
Few, if any, additional SNP and haplotype associations were observed in other pathways investigated in this study. For instance, BIK and EPHX2 were the only genes associated with NHL in the immunity and xenobiotic metabolism/oxidative stress pathways, respectively, and no NHL-genetic associations were observed in the sunlight/vitamin D or folate metabolism pathways. Previous studies suggest that SNPs in these pathways may influence lymphoma risk [2]. Our inability to validate these associations here may be that our study was underpowered to detect significant associations after adjusting for multiple comparisons; that our study had incomplete gene coverage; or that other genetic mechanisms such as copy number variation influenced the results. Thus, negative results reported here do not dismiss the potential relevance of these SNPs/pathways in lymphomagenesis, which will require further study in larger populations.
###end p 54
###begin title 55
Perspectives and Future Directions
###end title 55
###begin p 56
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1779 1783 1779 1783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Sherry1">[45]</xref>
###xml 1784 1788 1784 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Wheeler1">[47]</xref>
This study reports novel associations with common variants in ESR1 and in the vitamin C receptor and matrix metalloproteinase gene families. Of particular importance is the replication of a significant association with FL and the ESR1 rs3020314 SNP in a second independent study of lymphoma, which suggests that estrogen bioavailability may be relevant in the pathogenesis of lymphoma. We also believe that the genetic associations that did not reach statistical significance in the replication study are noteworthy, but due to the sample size, may have been underpowered to detect subtle allelic associations. Given the fact that we adjusted for multiple comparisons for pathways and did not adjust for all comparisons with all NHL subtypes, there still is an increased chance for type 1 errors and it is possible that some of our results are false positive associations. These findings will need further validation in larger studies. Owing to the small number of SNPs analyzed in the replication study, investigation of associated SNPs identified in the U.S. population will be ongoing. Further replication, fine mapping and functional studies will also be needed to determine the causal variants, and pooled data from consortium studies will be necessary to discern more modest effects of low penetrance SNPs or for rare alleles. The verification of these findings could have important implications by providing mechanistic clues in the etiology of lymphoma and in identifying useful therapeutic targets. Interestingly, most associations were found for FL and SLL/CLL and few were identified for DLBCL. This may be due to the heterogeneity of the disease since GC- and post-GC types of DLBCL exhibit significant molecular diversity at the gene expression and phenotype levels [45]-[47] that may require further stratification to detect underlying DLBCL risk alleles. It may also be that our hypothesis-driven approach failed to interrogate the appropriate pathways. To overcome this, we are currently performing a whole genome scan that will potentially lead to the identification of novel DLBCL susceptibility alleles.
###end p 56
###begin title 57
Materials and Methods
###end title 57
###begin title 58
U.S. Study Population
###end title 58
###begin p 59
###xml 956 960 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-JaffeES1">[40]</xref>
###xml 200 212 <span type="species:ncbi:9606">participants</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 994 1006 <span type="species:ncbi:9606">participants</span>
###xml 1256 1268 <span type="species:ncbi:9606">participants</span>
###xml 1422 1428 <span type="species:ncbi:9606">person</span>
###xml 1545 1551 <span type="species:ncbi:9606">person</span>
###xml 1655 1658 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1767 1779 <span type="species:ncbi:9606">participants</span>
###xml 1790 1796 <span type="species:ncbi:9606">person</span>
###xml 1971 1983 <span type="species:ncbi:9606">participants</span>
Cases were identified within approximately1 month of diagnosis by the Northern California Cancer Center's rapid case ascertainment. For this interim analysis which includes only a subset of the study participants, eligible patients were diagnosed with incident NHL from 10/2001-10/2005. All eligible patients were 20-84 years old and residents of one of six Bay Area counties at the time of diagnosis. There were 1704 eligible cases interviewed between 10-2001 and 10-2005. An additional 452 cases died prior to initial contact, 272 could not complete an interview in English, 70 had physician indicated contraindications to contact, 161 could not be located/moved, 155 were too ill and 360 refused to participate. Pathology reports and diagnostic materials were obtained from the diagnosing pathology department and re-reviewed by an expert pathologist to confirm the diagnosis and to provide a consistent classification of NHL subtypes using the REAL/WHO[40] lymphoma classification. Control participants were identified by random digit dial supplemented by random sampling of Centers for Medicare & Medicaid Services lists for those >/=65 years old. Eligibility criteria for controls were identical to cases with the exception of NHL diagnosis. Control participants were frequency matched to cases by age within five years, sex and county of residence. Among 1939 eligible random-digit-dial controls, 1313 completed in-person interviews, 85 were too ill and 541 refused to participate. Among 1475 eligible Medicare controls, 768 completed in-person interviews, 97 were too ill and 610 refused to participate. Demographic and risk factor data including HIV status, self-reported race and ethnicity, and paternal and maternal ancestry, were collected from all study participants during in-person interviews. No proxy interviews were conducted. The median time from diagnosis to venipuncture was 6.5 months. Blood and/or buccal cell specimens were collected for eligible participants who agreed to biospecimen collection (87% of cases, 88% of controls).
###end p 59
###begin title 60
German Study Population
###end title 60
###begin p 61
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Becker1">[41]</xref>
Detailed information regarding the design of this population-based case-control study has been published elsewhere[41]. Briefly, the study was carried out from 1999-2002 in six regions of Germany among 18-80 year-old adults. The study included 710 cases of DLBCL, FL, CLL, multiple myeloma (MM), MALT lymphoma, T-cell lymphoma and Hodgkin lymphoma (HL) and 710 controls individually matched by sex, age (+/-1 year of birth) and study region. Of these, there were 494 NHL cases and 111 HL cases and matched controls. The median time from diagnosis to blood collection was 27 days and the response rate for cases and controls was 87% and 44%, respectively. Analyses for all NHL did not include MM or HL. For subtype-specific analyses, only FL, DLBCL, CLL and HL were considered. Incident lymphoma cases were recruited from hospitals and office-based physicians involved in diagnosis and treatment of lymphoma in the study regions, interviewed by trained interviewers and provided blood samples. Cases were classified according to the WHO system based on pathology reports and 20% of cases were re-reviewed by a team of lymphoma pathologists.
###end p 61
###begin p 62
###xml 36 41 <span type="species:ncbi:9606">Human</span>
###xml 98 103 <span type="species:ncbi:9606">Human</span>
###xml 192 204 <span type="species:ncbi:9606">participants</span>
The U.C. San Francisco Committee on Human Research, the U.C. Berkeley Committee for Protection of Human Subjects, and the Ethics Committee, European Union, approved study protocols. All study participants provided written informed consent prior to interview and biospecimen collection.
###end p 62
###begin title 63
Pathway, Gene and SNP Selection
###end title 63
###begin p 64
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t001">Table 1</xref>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 148 156 148 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s009">Table S5</xref>
###xml 760 764 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Clamp1">[42]</xref>
###xml 765 769 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Wheeler1">[47]</xref>
###xml 838 842 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Barrett1">[48]</xref>
###xml 1021 1025 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Phillips1">[43]</xref>
###xml 1027 1031 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-1">[49]</xref>
Eight pathways or groups of genes with common biological function in a total of 146 genes (Table 1) were chosen to investigate a priori hypotheses (Table S5) in steroidogenesis, immune function, cell signaling, sunlight exposure/vitamin D, xenobiotic metabolism/oxidative stress, energy balance, cholesterol synthesis/metabolism and diet (folate and vitamin C uptake and/or metabolism) pathways. 1-15 SNPs in each gene and a total of 768 SNPs were selected using a minimum minor allele frequency criterion of >/=10%, based upon HapMap data release 12 (approximatelyOctober 2004) for CEU Caucasian samples. Additional coding and regulatory SNPs, especially those with non-synonymous amino acid changes, were identified using Ensembl, NCBI, and SNPper databases [42]-[47]. For all genes, haplotype tagging SNPs were selected using Haploview[48] after downloading SNP genotyping information available for the CEPH population (Utah residents with ancestry from northern and western Europe) from the HapMap database (Build 34)[43], [49]. SNP validation scores between 0 and 1 were generated using the Illumina Assay Design Tool to estimate the likelihood that SNPs would be successfully genotyped. Through an iterative process, we dropped SNPs with validation scores <0.6 and replacement haplotype tagging SNPs were identified using Haploview until a complete panel of 768 SNPs were chosen. This SNP panel (GS0006402-OPA) was custom designed by Illumina.
###end p 64
###begin title 65
Genotyping
###end title 65
###begin p 66
###xml 905 909 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-FakhraiRad1">[50]</xref>
For the U.S. study, genotyping was performed using the Illumina GoldenGate assay on a BeadStation 500G Genotyping System. Genotype calls were made using the GenCall version 6.2.0.4 software package (Illumina, Inc., San Diego, CA). Summary files were generated using the GTS Reports version 5.1.2.0. All SNPs were examined for cluster separation using Illumina quality scores that were automatically generated by the software. Poorly performing loci were excluded, designated with a GenTrain score <0.4 or a cluster separation score <0.6. SNPs were further excluded for scattered or overlapping clusters, for controls not in Hardy-Weinberg equilibrium, for low frequency (<0.05), or for DNA samples with low intensity. Individual DNA samples were excluded from the study if there was no signal across SNPs. Genotyping of the German study was performed by Pyrosequencingtrade mark (Biotage, Uppsala, Sweden)[50].
###end p 66
###begin title 67
Quality assurance
###end title 67
###begin p 68
To validate genotyping results, each 96-well plate contained 90 randomized study samples, two randomized replicate study samples placed side-by-side and three laboratory control DNA samples. DNA also was genotyped from six CEPH families (Coriell Institute, Camden, NJ). Genotyping of 10 SNPs was performed for validation purposes using TaqMan(R) genotyping assays and the ABI Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, CA).
###end p 68
###begin title 69
Coverage estimation
###end title 69
###begin p 70
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Barrett1">[48]</xref>
###xml 442 443 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Coverage which indicates the fraction of common HapMap markers successfully tagged by the set of genotyped SNPs was estimated using the pairwise tagging method in Haploview[48], which is based on the Tagger algorithm (). SNPs genotyped were forced into a tag list and neighboring HapMap SNPs were explicitly prohibited from being chosen as tags. We specified that all HapMap markers being captured by the set of tags should be correlated at R2>/=0.8 with at least one marker in the set. HapMap markers with MAF<0.05 were excluded.
###end p 70
###begin title 71
Statistical Analyses
###end title 71
###begin p 72
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Tang1">[51]</xref>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 57 69 <span type="species:ncbi:9606">participants</span>
All statistical analyses were restricted to HIV-negative participants of white non-Hispanic origin (959 cases, 1,049 controls). Because self identified ethnicity and ancestry correlates very well with genetic structure [51], using this information greatly minimizes the potential effect of underlying population stratification on the risk estimates. Hardy-Weinberg equilibria for genotype frequencies among controls were determined by exact tests using a Markov-chain method (Genepop v3.4).
###end p 72
###begin title 73
SNP analysis
###end title 73
###begin p 74
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Benjamini1">[52]</xref>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t002">Tables 2</xref>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002816-t003">3</xref>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Breslow1">[53]</xref>
Exact tests were used to generate p-values to test associations of case-control status and SNP associations. For each pathway, P-values were corrected for multiple comparisons (q-values) using the false discovery rate[52]. For all NHL, and for each subtype tested, the following total number of SNP tests were performed in each pathway: steroidogenesis, 88; immunity, 75; cell signaling, 88; sunlight/vitamin D, 53; xenobiotic/metabolism, 40; energy balance, 155; cholesterol, 62; and diet, 26. Fifty intergenic SNPs were excluded from the pathway analyses. A threshold of q<0.10 was used in reporting the most relevant findings in Tables 2 and 3. ORs and 95% CIs as estimates of the relative risk were computed adjusted by age and sex from unconditional logistic regression [53] without taking into account multiple testing. In genotype analyses, the wild-type category (chosen either as the most common homozygous genotype or arbitrarily if the same) was the reference group. The odds ratios from the unconditional logistic models were adjusted for the frequency-matched variables age in 5-year groups and sex. Analyses were performed on all NHL cases and then stratified by DLBCL, FL, SLL/CLL and "others." We did not adjust for all multiple comparisons for all SNPs in all types of lymphoma.
###end p 74
###begin title 75
Gene analysis
###end title 75
###begin p 76
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We tested for multi-way interactions within sets of SNPs spanning a gene by fitting the genotypes to a linear regression model and applying a t-test to the case-control distributions. P-values were generated by permuting cases and controls, repeating the experiment 10,000 times per gene. Results were adjusted for multiple hypotheses testing using the FDR for each functional group/pathway. For "all NHL" and for each subtype tested, the following total number of gene tests were performed: steroidogenesis, 22; immunity, 22; cell signaling, 19; sunlight/vitamin D, 12; xenobiotic/metabolism, 14; energy balance, 38; cholesterol, 19; and diet, 9.
###end p 76
###begin title 77
Haplotype analysis
###end title 77
###begin p 78
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Halperin1">[54]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Zhang1">[55]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Stephens1">[56]</xref>
###xml 240 241 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
SNPs were partitioned into blocks of limited diversity using HAP[54], which uses criteria similar to previous methods[55]. For each block of limited diversity, genotypes were phased using PHASE[56]. For each common haplotype (MAF>5%), a chi2-test with one degree of freedom was performed with counts of haplotype occurrences in cases and controls. Results were adjusted for multiple hypotheses using the FDR for each functional group/pathway. For "all NHL" and for each subtype tested, the following total number of haplotype tests were performed: steroidogenesis, 44; immunity, 38; cell signaling, 45; sunlight/vitamin D, 31; xenobiotic/metabolism, 19; energy balance, 91; cholesterol, 36; and diet, 12.
###end p 78
###begin title 79
Replication study
###end title 79
###begin p 80
Conditional logistic regression analysis was used to estimate ORs and 95% CIs comparing cases (all NHL cases combined -which excluded MM and HL- and individual FL, DLBCL and SLL/CLL subtypes and separate analyses for HL) to respective controls in association with genotypes, adjusting for gender, age and study region.
###end p 80
###begin title 81
In silico algorithms
###end title 81
###begin p 82
###xml 22 26 22 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Yuan1">[57]</xref>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Fairbrother1">[13]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Cartegni1">[58]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002816-Ramensky1">[59]</xref>
The FASTSNP web server[57] was used to interrogate 11 external web servers including RESCUE-ESE[13], ESEfinder[58] and PolyPhen[59] to predict the functionality of SNPs.
###end p 82
###begin title 83
Supporting Information
###end title 83
###begin p 84
###xml 282 292 282 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s001">Figures S1</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s002">S2</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s003">S3</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002816.s004">S4</xref>
LD plot characterizing haplotype blocks in SCL23A2. The 7 SLC23A2 SNPs genotyped (rs2298174, rs1629176, rs1715385, rs6133175, rs1715364, rs1776948 and rs6139587 highlighted in green) captured 35% of genetic variation for the SLC23A2 locus. Detailed description of LD plots shown in Figures S1, S2, S3 and S4. R2 values are indicated in percentages within squares in the LD plot, where red indicates regions of high LD and white represents regions of low LD. Blocks without numbers indicate r2 = 1 (100%). At the top, figures display a track with HapMap genotyped SNPs and genes within the genomic region. SNPs that have been genotyped in this study are highlighted in green and marked with lines from the SNP position to the LD chart. LD blocks were generated using the Confidence Intervals method included in Haploview4.0 (), that creates 95% confidence bounds on D' considered to be in strong LD where 95% of the comparisons made are informative. Genotype data was retrieved from HapMap release 22/phaseII (NCBI B36 assembly), for the CEPH (Centre d'Etude du Polymorphisme Humain) from Utah (CEU). Coverages were obtained using the tagging method included in Haploview as described in the manuscript.
###end p 84
###begin p 85
(59.29 MB DOC)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
LD plot characterizing haplotype blocks in MMP9. The 5 MMP9 SNPs genotyped (rs6094237, rs4810482, rs3918241, rs17576 and rs2274756), highlighted in green, captured 15 out of 19 variations (78%) with r2>0.8. There is, therefore, good coverage of the MMP9 gene.
###end p 87
###begin p 88
(2.58 MB DOC)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
LD plot characterizing haplotype blocks in CYP19A1. The 14 CYP19A1 SNPs genotyped (rs10046, rs2289105, rs2899472, rs9944225, rs4775936, rs2008691, rs4774584, rs7181886, rs936306, rs1004982, rs2470146, rs2470144, rs1870049 and rs752760 highlighted in green) captured 66% of genetic variation for CYP19A1.
###end p 90
###begin p 91
(72.13 MB DOC)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
LD plot characterizing haplotype blocks in ESR1. The 11 ESR1 SNPs genotyped (rs2881766, rs488133, rs532010, rs827423, rs1709182, rs1913474, rs3020314, rs722208, rs3020411, rs2813545 and rs910416 highlighted in green) captured 66 out of 262 SNPs at r2>0.8, providing 25% gene coverage.
###end p 93
###begin p 94
(70.04 MB DOC)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
Odds ratios (OR) and 95% confidence intervals (CI) for associated SLC23A1 and SLC23A SNPs in the San Francisco Bay Area NHL study.
###end p 96
###begin p 97
(0.11 MB DOC)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
Odds ratios (OR) and 95% confidence intervals (CI) for associated MMP1, 3 and 9 SNPs in the San Francisco Bay Area NHL study.
###end p 99
###begin p 100
(0.14 MB DOC)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
Odds ratios (OR) and 95% confidence intervals (CI) for associated CYP19A1 SNPs in the San Francisco Bay Area NHL study.
###end p 102
###begin p 103
(0.16 MB DOC)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
Odds ratios (OR) and 95% confidence intervals (CI) for associated ESR1 SNPs in the San Francisco Bay Area NHL study.
###end p 105
###begin p 106
(0.12 MB DOC)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
A priori hypotheses tested.
###end p 108
###begin p 109
(0.06 MB DOC)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin title 111
References
###end title 111
###begin article-title 112
The non-Hodgkin lymphomas: a review of the epidemiologic literature.
###end article-title 112
###begin article-title 113
Genetic susceptibility to lymphoma.
###end article-title 113
###begin article-title 114
Lymphoma and the control of B cell growth and differentiation.
###end article-title 114
###begin article-title 115
Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
###end article-title 115
###begin article-title 116
Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.
###end article-title 116
###begin article-title 117
Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.
###end article-title 117
###begin article-title 118
Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.
###end article-title 118
###begin article-title 119
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma.
###end article-title 119
###begin article-title 120
Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma.
###end article-title 120
###begin article-title 121
Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma.
###end article-title 121
###begin article-title 122
Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
###end article-title 122
###begin article-title 123
Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms.
###end article-title 123
###begin article-title 124
###xml 58 63 <span type="species:ncbi:9606">human</span>
Predictive identification of exonic splicing enhancers in human genes.
###end article-title 124
###begin article-title 125
###xml 52 55 <span type="species:ncbi:9606">men</span>
###xml 60 65 <span type="species:ncbi:9606">women</span>
Dietary factors and risk of non-hodgkin lymphoma in men and women.
###end article-title 125
###begin article-title 126
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy.
###end article-title 126
###begin article-title 127
SVCT1 and SVCT2: key proteins for vitamin C uptake.
###end article-title 127
###begin article-title 128
Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells.
###end article-title 128
###begin article-title 129
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival.
###end article-title 129
###begin article-title 130
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Gender and sodium-ascorbate transporter isoforms determine ascorbate concentrations in mice.
###end article-title 130
###begin article-title 131
Vitamin C. Biosynthesis, recycling and degradation in mammals.
###end article-title 131
###begin article-title 132
Ascorbate peroxidase, a scavenger of hydrogen peroxide in glyoxysomal membranes.
###end article-title 132
###begin article-title 133
Biological role of vitamin C in keratinocytes.
###end article-title 133
###begin article-title 134
Ascorbic acid induces apoptosis in adult T-cell leukemia.
###end article-title 134
###begin article-title 135
Matrix metalloproteinases in tumour invasion and metastasis.
###end article-title 135
###begin article-title 136
Matrix metalloproteinases in tumor invasion and metastasis.
###end article-title 136
###begin article-title 137
###xml 130 135 <span type="species:ncbi:9606">human</span>
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.
###end article-title 137
###begin article-title 138
Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas.
###end article-title 138
###begin article-title 139
Hematopoietic cancer and angiogenesis.
###end article-title 139
###begin article-title 140
###xml 57 60 <span type="species:ncbi:10116">rat</span>
Studies on the mechanism of estrogen biosynthesis in the rat ovary-I.
###end article-title 140
###begin article-title 141
###xml 45 50 <span type="species:ncbi:9606">human</span>
Regulation of aromatase promoter activity in human breast tissue by nuclear receptors.
###end article-title 141
###begin article-title 142
The association of bone mineral density with estrogen receptor gene polymorphisms.
###end article-title 142
###begin article-title 143
Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche.
###end article-title 143
###begin article-title 144
Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities.
###end article-title 144
###begin article-title 145
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Estrogen receptor in the "non-lymphocytes" in the thymus of the ovariectomized rat.
###end article-title 145
###begin article-title 146
[Hepatitis B: infective agent, infection transmission, infection recipient].
###end article-title 146
###begin article-title 147
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse.
###end article-title 147
###begin article-title 148
Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations.
###end article-title 148
###begin article-title 149
###xml 24 29 <span type="species:ncbi:9606">Women</span>
Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone Use.
###end article-title 149
###begin article-title 150
###xml 94 99 <span type="species:ncbi:9606">women</span>
Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women.
###end article-title 150
###begin article-title 151
World Health Organization Classification of lymphomas: a work in progress.
###end article-title 151
###begin article-title 152
Population-based study of lymphoma in Germany: rationale, study design and first results.
###end article-title 152
###begin article-title 153
Ensembl 2002: accommodating comparative genomics.
###end article-title 153
###begin article-title 154
Online resources for SNP analysis: a review and route map.
###end article-title 154
###begin article-title 155
###xml 34 39 <span type="species:ncbi:9606">human</span>
SNPper: retrieval and analysis of human SNPs.
###end article-title 155
###begin article-title 156
dbSNP: the NCBI database of genetic variation.
###end article-title 156
###begin article-title 157
dbSNP: a database of single nucleotide polymorphisms.
###end article-title 157
###begin article-title 158
Database resources of the National Center for Biotechnology Information: 2002 update.
###end article-title 158
###begin article-title 159
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 159
###begin article-title 160
The International HapMap Project.
###end article-title 160
###begin article-title 161
Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms.
###end article-title 161
###begin article-title 162
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies.
###end article-title 162
###begin article-title 163
Controling the false discovery rate: a practical and powerful approach to multiple testing. Series B (methodological).
###end article-title 163
###begin article-title 164
Statistical methods in cancer research.
###end article-title 164
###begin article-title 165
Haplotype reconstruction from genotype data using Imperfect Phylogeny.
###end article-title 165
###begin article-title 166
A hidden Markov modeling approach for admixture mapping based on case-control data.
###end article-title 166
###begin article-title 167
A new statistical method for haplotype reconstruction from population data.
###end article-title 167
###begin article-title 168
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.
###end article-title 168
###begin article-title 169
ESEfinder: A web resource to identify exonic splicing enhancers.
###end article-title 169
###begin article-title 170
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey.
###end article-title 170
###begin article-title 171
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
###end article-title 171
###begin article-title 172
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States).
###end article-title 172
###begin article-title 173
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
###end article-title 173
###begin article-title 174
Obesity, diet and risk of non-Hodgkin lymphoma.
###end article-title 174
###begin article-title 175
Prior history of allergies and pancreatic cancer in the San Francisco Bay area.
###end article-title 175
###begin article-title 176
###xml 51 56 <span type="species:ncbi:9606">women</span>
###xml 74 77 <span type="species:ncbi:9606">men</span>
Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California.
###end article-title 176
###begin article-title 177
Statin use and risk of lymphoid neoplasms: results from the European Case-Control Study EPILYMPH.
###end article-title 177
###begin article-title 178
###xml 48 66 <span type="species:ncbi:10376">Epstein-Barr virus</span>
HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma.
###end article-title 178
###begin article-title 179
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
###end article-title 179
###begin p 180
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 180
###begin p 181
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grant numbers CA122663 (CFS), CA104862 (MTS) and CA45614, CA89745, CA87014 (EAH), and the German Jose Carreras Leukaemia foundation (DJCLS_R04/08) (AN).
###end p 181

